Key Barrier to Heart Cell Self-Repair Identified

Cellular reprogramming to repair damaged heart tissue faces a major hurdle as scientists uncover how carbohydrate sulfotransferase 7 (CHST7) and CD44 receptors lock cellular identities in place, according to research published July 17, 2026, in Nature Communications by teams at the Sanford Burnham Prebys Medical Discovery Institute and The Johns Hopkins University School of Medicine. … Read more

Genetic Susceptibility and Cancer Progression: What New Research Reveals

Inherited genetics directly shape how our DNA interacts with acquired mutations to drive tumor evolution, according to research published in Nature. Scientists at the University of Cambridge and the University of Edinburgh found that an individual’s genetic background dictates both cancer risk and the specific evolutionary paths tumors take, offering new direction for precision medicine … Read more

Genome Folding Linked to Alzheimer’s Brain Organization

Researchers at Carnegie Mellon University, the University of Pittsburgh, and the University of Washington have mapped how 3D genome architecture differs in brain cells affected by Alzheimer’s disease. According to a study published in Science, the research team linked genome folding to gene activity and brain tissue organization using single-cell technology, spatial mapping, and a … Read more

Unexpected Mechanism Drives Extreme Antibiotic Resistance, Study Reveals

Rapidly developing antibiotic resistance during severe lung infections can occur when patients acquire circular pieces of DNA called plasmids from transient environmental bacteria, according to researchers at the University of Washington School of Medicine. Publishing their findings in Nature Microbiology, the team reported that this gene transfer can cause pathogen resistance to jump more than … Read more

How DNA Enhancer Hubs Drive Prostate Cancer Genes

Researchers at the Keck School of Medicine of USC have identified a 3D hierarchy of DNA “enhancers” that function as master switches for prostate cancer development. According to a study published in Genome Biology, these interconnected networks control gene expression, revealing potential new targets for precision cancer therapies that could move beyond current gene-specific treatments. … Read more

5 Epigenetic Clocks: Shared and Distinct Aging Signals

Epigenetic clocks—tools designed to measure biological age through DNA methylation—capture distinct, non-overlapping biological processes rather than a single universal aging mechanism. According to a study published in npj Aging, researchers have developed Transcriptomic Aging Gene Scores (TAGS) to better interpret these clocks, showing that gene expression patterns often predict health outcomes like mortality and frailty … Read more

Tailored Gene Therapy Significantly Reduces Childhood Epilepsy Seizures

Researchers at the University of California San Diego and the Rady Children’s Institute for Genomic Medicine have successfully treated two children with SCN2A-related developmental epileptic encephalopathy (DEE) using personalized, allele-selective antisense oligonucleotides (ASOs). According to a study published July 21, 2026, in Nature Medicine, the therapy reduced seizure frequency by up to 90%, improved developmental … Read more

Advancing Precision Oncology with New Tumor Organoids

Patient-derived tumor organoids are emerging as high-fidelity preclinical models for precision oncology, offering a way to test cancer treatments on three-dimensional cell clusters that mirror a patient’s specific disease. Recent research led by investigators at Weill Cornell Medicine demonstrates that these “avatars” can reliably predict treatment sensitivity, potentially expanding the pool of patients eligible for … Read more

New Portable Strip Test Rapidly Detects Mosquito-Borne Viruses

Researchers at China Pharmaceutical University have developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that detects mosquito-borne viruses like Chikungunya (CHIKV) with high sensitivity without the need for specialized laboratory equipment. According to a study published in Targetome on April 30, 2026, the method achieves a visual detection limit of 2 pmol·L−1, offering a portable … Read more

Optimizing Liver Cancer Treatment via Gene Signatures and Multi-Omics

Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more